seed
Stage
2
Investors
About
MGShell develops a magnesium-based drug delivery platform aimed at improving treatments for retinal diseases by enhancing patient adherence and reducing healthcare costs.
Explore MGShell's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.